Viewing Study NCT03931551


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-02-22 @ 4:13 PM
Study NCT ID: NCT03931551
Status: TERMINATED
Last Update Posted: 2023-02-22
First Post: 2019-04-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Olaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast Cancer
Sponsor: MedSIR
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module